Results 241 to 250 of about 1,032,308 (279)
Some of the next articles are maybe not open access.

Synthetic Cannabinoids

The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills   +2 more
openaire   +2 more sources

Focus on cannabinoids and synthetic cannabinoids

Clinical Pharmacology & Therapeutics, 2016
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the endocannabinoid system is involved in many physiological processes that are increasingly explored.
R, Le Boisselier   +3 more
openaire   +2 more sources

Synthetic Cannabinoids

2023
New synthetic cannabinoid agonists have been synthesized during the last decades and promoted for their psychoactive effects, mimicking those of delta-9-tetrahydrocannabinol. These newest cannabimimetic drugs show binding affinities for the cannabinoid CB1 and/or the CB2 receptors.
Fattore, Liana, Marti, Matteo
openaire   +2 more sources

Psychosis and synthetic cannabinoids

Psychiatry Research, 2018
Synthetic cannabinoid (SC) products have gained popularity as abused drugs over the past decade in many countries. The SCs broadly impact psychological state (e.g., mood, suicidal thoughts and psychosis) and physiological functions (e.g., cardiovascular, gastrointestinal and urinary).
Huiqiong Deng   +3 more
openaire   +2 more sources

Nonpsychotropic Synthetic Cannabinoids

Current Pharmaceutical Design, 2000
Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer, does not have affinity toward cannabinoid receptors and is devoid of cannabimimetic activity. On the other hand, dexanabinol demonstrated significant neuroprotective properties which prompted its development as a therapeutic ...
openaire   +2 more sources

Toxicology of synthetic cannabinoids

Annales de Biologie Clinique
Synthetic cannabinoids (CS), or synthetic endocannabinoid receptor agonists, were initially synthesized for basic research into exocannabinoid signaling pathways, as well as in clinical research for their analgesic properties. The use of CS for recreational purposes is a recent phenomenon, but one that has grown very quickly in recent years, since ...
Youssef, Mouraouakkil   +5 more
openaire   +2 more sources

Synthetic Cannabinoids

Sentetik kannabinoidler SK , kannabinollerin bir alt grubu olup, son yıllarda uyuşturucu kullanımında çok ön planda yer almaya başlamıştır. Bu maddelerin kullanımı günümüzde özellikle gençlerde ve genç erişkinlerde artmaktadır. Hem zehirlenmeler nedeni ile Acil servislere başvuran olgular her geçen gün artmakta, hem de ölümle sonuçlanan olgular ...
PAKİŞ, Işıl, POLAT, Oğuz
  +5 more sources

Synthetic cannabinoids revealing adrenoleukodystrophy

Journal of Clinical Neuroscience, 2016
We report a 41-year-old man who presented with a first generalized tonic-clonic seizure after recent consumption of a synthetic cannabinoid. MRI showed extensive bilateral, mainly frontal, white matter lesions. Blood analysis for very long chain fatty acids was compatible with adrenoleukodystrophy, and a missense mutation in the ABCD1 gene confirmed ...
Avi, Fellner   +2 more
openaire   +2 more sources

Blood concentrations of synthetic cannabinoids

Clinical Toxicology, 2020
Synthetic cannabinoids (SCs) are the largest and most diverse group of new psychoactive substances. Their influence on organism is unpredictable and often lead to intoxications, including fatal poisonings. The interpretation of blood concentrations of detected SC although complicated, can help to determine the effects of an administered drug.
openaire   +2 more sources

Synthetic Cannabinoid Use

Journal of Psychiatric Practice, 2012
In the past few years, synthetic cannabinoid products have been increasingly used by adolescents and young adults. These products are marketed as herbal or aromatic incense and potpourri, but their psychoactive properties appear to be due to the addition of synthetic cannabinoids.
Daniel, Castellanos, Gabriel, Thornton
openaire   +2 more sources

Home - About - Disclaimer - Privacy